Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy
Kevin J. Frankowski(University of Kansas), Jeffrey Aubé(University of North Carolina at Chapel Hill), Laura Bohn(Scripps Research Institute), Marc G. Caron(Duke University), Shenghua Shi(Sanford Burnham Prebys Medical Discovery Institute), Layton H. Smith(Sanford Burnham Prebys Medical Discovery Institute), Santosh Hariharan(Pfizer (United States)), Stefan Vasile(Sanford Burnham Prebys Medical Discovery Institute), Thomas E. Prisinzano(University of Kentucky), John M. Streicher(University of Arizona), Frank J. Schoenen(University of Kansas), Arianna Mangravita-Novo(Sanford Burnham Prebys Medical Discovery Institute), Palak Gosalia(Sanford Burnham Prebys Medical Discovery Institute), Kelin Li(University of Kansas), Ying Su(Sanford Burnham Prebys Medical Discovery Institute), Michael Vicchiarelli(Sanford Burnham Prebys Medical Discovery Institute), Susanne Heynen‐Genel(Sanford Burnham Prebys Medical Discovery Institute), Wilson Gray(Sanford Burnham Prebys Medical Discovery Institute), Lawrence S Barak(Duke University), Partha Ghosh(University of Kansas), Loribelle Milan(Sanford Burnham Prebys Medical Discovery Institute), Michael P. Hedrick(Sanford Burnham Prebys Medical Discovery Institute), Eduard Sergienko(Sanford Burnham Prebys Medical Discovery Institute), David A. Whipple(University of Kansas), Thomas D.Y. Chung(Sanford Burnham Prebys Medical Discovery Institute)
Cited by 56
Related Papers
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
|Cell|2005|966
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
|Annual Review of Neuroscience|2004|859
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
|Proceedings of the National Academy of Sciences|2004|786
Tryptophan Hydroxylase-2 Controls Brain Serotonin Synthesis
|Science|2004|685
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
|The Annual Review of Pharmacology and Toxicology|2008|521